#AANAM – Kesimpta, Added to NHS in UK, Prevents Worsening in New Patients

#AANAM – Kesimpta, Added to NHS in UK, Prevents Worsening in New Patients

292389

#AANAM – Kesimpta, Added to NHS in UK, Prevents Worsening in New Patients

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. Kesimpta (ofatumumab) may now be prescribed through the National Health Service (NHS) of England and Wales as an at-home, self-administered treatment for people with relapsing-remitting multiple sclerosis (RRMS) who are either having relapses or have other evidence of MS activity. A poster presentation at the AAN meeting, based…

You must be logged in to read/download the full post.